Literature DB >> 18000257

Beta-agonists: all the facts please.

Anthony D D'Urzo.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 18000257      PMCID： PMC2231473     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  7 in total

1.  Meta-analysis: respiratory tolerance to regular beta2-agonist use in patients with asthma.

Authors:  Shelley R Salpeter; Thomas M Ormiston; Edwin E Salpeter
Journal:  Ann Intern Med       Date:  2004-05-18       Impact factor: 25.391

2.  Should we avoid beta-agonists for moderate and severe chronic obstructive pulmonary disease? YES.

Authors:  Shelley R Salpeter
Journal:  Can Fam Physician       Date:  2007-08       Impact factor: 3.275

Review 3.  Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.

Authors:  L P Boulet; A Becker; D Bérubé; R Beveridge; P Ernst
Journal:  CMAJ       Date:  1999-11-30       Impact factor: 8.262

4.  Inhaled corticosteroids and mortality in COPD.

Authors:  Christine Macie; Kate Wooldrage; Jure Manfreda; Nicholas R Anthonisen
Journal:  Chest       Date:  2006-09       Impact factor: 9.410

5.  Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

Authors:  R A Pauwels; C G Löfdahl; D S Postma; A E Tattersfield; P O'Byrne; P J Barnes; A Ullman
Journal:  N Engl J Med       Date:  1997-11-13       Impact factor: 91.245

6.  Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease.

Authors:  D D Sin; L Wu; J A Anderson; N R Anthonisen; A S Buist; P S Burge; P M Calverley; J E Connett; B Lindmark; R A Pauwels; D S Postma; J B Soriano; W Szafranski; J Vestbo
Journal:  Thorax       Date:  2005-10-14       Impact factor: 9.139

7.  Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

Authors:  Peter M A Calverley; Julie A Anderson; Bartolome Celli; Gary T Ferguson; Christine Jenkins; Paul W Jones; Julie C Yates; Jørgen Vestbo
Journal:  N Engl J Med       Date:  2007-02-22       Impact factor: 91.245
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.